Welcome to the RELIEF Site portal,

Please use the navigation bar to access various study tools and references.

Trial is approved by the FDA (IDE#17234)

Funded by the Biomedical Advanced Research and Development Authority

Within the Office of the Assistant Secretary for Preparedness and Response; Department of Health and Human Services

Sponsor: Cytori Therapeutics Inc.

CRO: PAREXEL